333 related articles for article (PubMed ID: 38672416)
1. Biomarkers for Managing Neurodegenerative Diseases.
Cheslow L; Snook AE; Waldman SA
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
[TBL] [Abstract][Full Text] [Related]
2. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
[TBL] [Abstract][Full Text] [Related]
3. Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease.
Shvetcov A; Thomson S; Spathos J; Cho AN; Wilkins HM; Andrews SJ; Delerue F; Couttas TA; Issar JK; Isik F; Kaur S; Drummond E; Dobson-Stone C; Duffy SL; Rogers NM; Catchpoole D; Gold WA; Swerdlow RH; Brown DA; Finney CA
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834458
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Neurodegenerative Diseases.
Jeromin A; Bowser R
Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
[TBL] [Abstract][Full Text] [Related]
5. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
6. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
7. Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis.
Carlomagno C; Banfi PI; Gualerzi A; Picciolini S; Volpato E; Meloni M; Lax A; Colombo E; Ticozzi N; Verde F; Silani V; Bedoni M
Sci Rep; 2020 Jun; 10(1):10175. PubMed ID: 32576912
[TBL] [Abstract][Full Text] [Related]
8. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
[TBL] [Abstract][Full Text] [Related]
9. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
Cagin U
Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
[TBL] [Abstract][Full Text] [Related]
10. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise on sleep in neurodegenerative disease.
Memon AA; Coleman JJ; Amara AW
Neurobiol Dis; 2020 Jul; 140():104859. PubMed ID: 32243913
[TBL] [Abstract][Full Text] [Related]
12. The Role of Bioenergetics in Neurodegeneration.
Strope TA; Birky CJ; Wilkins HM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
[TBL] [Abstract][Full Text] [Related]
13. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
[TBL] [Abstract][Full Text] [Related]
14. Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.
Nicoletti A; Baschi R; Cicero CE; Iacono S; Re VL; Luca A; Schirò G; Monastero R;
Mech Ageing Dev; 2023 Jun; 212():111821. PubMed ID: 37127082
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
Jankowsky JL; Savonenko A; Schilling G; Wang J; Xu G; Borchelt DR
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):457-64. PubMed ID: 12169227
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
[TBL] [Abstract][Full Text] [Related]
17. Molecular biomarkers of neurodegeneration.
Höglund K; Salter H
Expert Rev Mol Diagn; 2013 Nov; 13(8):845-61. PubMed ID: 24151849
[TBL] [Abstract][Full Text] [Related]
18. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Kori M; Aydın B; Unal S; Arga KY; Kazan D
OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin E on neurodegenerative diseases: an update.
Icer MA; Arslan N; Gezmen-Karadag M
Acta Neurobiol Exp (Wars); 2021; 81(1):21-33. PubMed ID: 33949169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
